ERBB2 and breast carcinoma: An integrative microarray data analysis using the Kaplan Meier Plotter [27] shows that low EcSOD expression is associated with significantly reduced relapse free survival in all breast cancer subtypes, including the basal-like (ER−, PR−, Her2−, CK 5/6+, and/or EGFR+) breast cancers (Table 1).